June 19-21, 2018 | Princeton, New Jersey, USA
Do you know how payers evaluate pharmaceutical products and other technologies in the United States and other leading markers? Are you interested in learning about issues and techniques related to the use and conduct of health technology assessment (HTA)? How is HTA in the US influenced by and influencing HTA in other countries? What are the current standards and practices for HTA? What specific analytical methods and tools are used? Due to the increasing costs of pharmaceuticals, HTA is becoming more and more important in the US. HTA plays an instrumental role in the advancement of evidence-based healthcare decision making. Do not miss this opportunity to learn from global HTA experts at the next ISPOR HTA Training Program held in June in New Jersey, USA!
By the end of the course, participants will be able to: